The weekly litigation news digest is live. Subscribe now

Antitumor T Cell Response Enhancer

Patent No. EP2578231 (titled "Antitumor T Cell Response Enhancer") was filed by Chugai Seiyaku Kabushiki Kaisha on May 27, 2011. The application was issued on Oct 26, 2022.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
GEDEON RICHTER PHARMAJul 25, 2023MAIWALD

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2578231

CHUGAI SEIYAKU KABUSHIKI KAISHA
Application Number
EP11786748A
Filing Date
May 27, 2011
Status
Revoked
Feb 14, 2025
Publication Date
Oct 26, 2022
External Links
Slate, Register, Google Patents